“Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience”, J. Anal. Oncol., vol. 3, no. 1, pp.  26–32, Jan. 2014, doi: 10.6000/1927-7229.2014.03.01.4.